MNMD - Mind Medicine - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNMD is currently covered by 1 analysts with an average price target of $20. This is a potential upside of $4.62 (30.04%) from yesterday's end of day stock price of $15.38.

Mind Medicine's activity chart (see below) currently has 44 price targets and 55 ratings on display. The stock rating distribution of MNMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.89% with an average time for these price targets to be met of 164.24 days.

Highest price target for MNMD is $20, Lowest price target is $20, average price target is $20.

Most recent stock forecast was given by from RBC on 07-Nov-2025.

Best performing analysts who are covering MNMD - Mind Medicine:

Brian Abrahams Charles Duncan Joel Beatty Rudy Li Gavin Clark-Gartner

Currently out of the existing stock ratings of MNMD, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Nov-2022

$20

$4.62 (30.04%)

$22

11 months ago
(07-Nov-2025)

8/11 (72.73%)

$8.3 (70.94%)

376

Buy Since 15-Apr-2024

$20

$4.62 (30.04%)

$20

1 years 4 months 28 days ago
(09-May-2025)

0/3 (0%)

$13.85 (225.20%)

Buy Since 25-Aug-2022

$20

$4.62 (30.04%)

$20

1 years 5 months 21 days ago
(16-Apr-2025)

1/4 (25%)

$14.54 (266.30%)

34

Buy Since 29-May-2024

$16

$0.62 (4.03%)

$27

1 years 7 months ago
(07-Mar-2025)

0/3 (0%)

$9.17 (134.26%)

Buy Since 05-Aug-2021

1 years 7 months ago
(07-Mar-2025)

1/5 (20%)

$48.99 (815.14%)

322

Show more analysts

Please expand the browser size to see the chart

What is MNMD (Mind Medicine) average time for price targets to be met?

On average it took 164 days for the stock forecasts to be reached, with an average price target met ratio of 26.89%.

Which analyst most recently updated their price target on MNMD (Mind Medicine)?

Which analyst has the most public recommendations on MNMD (Mind Medicine)?

has 0 price targets and 0 ratings on MNMD

Which analyst is the currently most bullish on MNMD (Mind Medicine)?

Jonathan Aschoff with the highest potential upside of $20.62

Which analyst is the currently most reserved on MNMD (Mind Medicine)?

Jason Mccarthy with the lowest potential downside of -$7.38
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?